HealthCare Global Enterprises Limited has completed the divestment of its entire equity shareholding in BACC Health Care Private Limited. The company transferred 93,577 shares, constituting approximately 99.999% of BACC, to Inviga Healthcare Fund I and its nominee on June 29, 2026. The transaction was executed pursuant to a Share Purchase Agreement dated May 19, 2026, approved by the board on the same day.

The total consideration for the sale is ₹37,64,44,788. Of this, the initial consideration of ₹28,23,33,591 was received on June 29, 2026. The remaining balance is a deferred consideration payable within 18 months from the date of signing the agreement, which is not conditional or contingent.

The transfer of one share held by a nominee on behalf of the company is currently under process. The divestment was intimated to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transaction Details

The board approval for the sale was granted on May 19, 2026. The deferred payment is strictly time-based and carries no additional conditions.

Dr. B.S. Ajaikumar, a promoter of healthcare global enterprises , has declared that no new encumbrances were created on the equity shares held by him during the financial year 2025–2026. The total number of encumbered shares as on March 31, 2026, stands at 49,59,539, representing 3.32% of the paid-up share capital of the company. This disclosure was made to the stock exchanges pursuant to Regulations 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The promoter detailed the historical encumbrances created in previous financial years, which contribute to the current total. These include 18,92,539 equity shares encumbered on March 12, 2025, and intimated to the exchanges on March 17, 2025. Additionally, 90,000 equity shares were encumbered on September 27, 2022, and 29,77,000 equity shares were encumbered on March 5, 2021, with respective intimations made on September 28, 2022, and March 8, 2021.

Dr. B.S. Ajaikumar confirmed that, other than the disclosed encumbrances, neither he nor the members of his family forming part of the Persons Acting in Concert (PAC) have created any encumbrance, directly or indirectly, on the equity shares of the company during the financial year ended March 31, 2026.

The declaration also referenced a Promoter Agreement dated February 23, 2025, executed between the BSA Promoter Group, Hector Asia Holdings II Pte. Ltd., and KIA EBT II Scheme 1, which became effective on May 30, 2025. Under this agreement, the BSA Promoter Group has undertaken not to transfer or encumber equity securities other than pursuant to specific clauses, including a Permitted Sale or an Eligible Pledge up to 5% of the share capital.

While the agreement records inter se rights and obligations, it does not create a third-party interest or encumbrance on the shares. A disclosure was made to the stock exchanges on June 9, 2025, as a matter of abundant caution regarding the broad definition of "encumbrance" under the SAST Regulations. Consequently, the number of encumbered shares remains unchanged following the effectiveness of the Promoter Agreement.

Details of Encumbrances